Beruflich Dokumente
Kultur Dokumente
Dr. N. Kumarjit Singh ENT Surgeon JNIMS, Porompat Imphal East IgE-mediated immunologic response of nasal mucosa to air-borne allergens Characteristics: Watery nasal discharge Nasal obstruction Sneezing Itchy nose, (eyes palate, pharynx)
Clinical Types
Seasonal Perennial
Pathogenesis
IgE production through inhaled allergens Antibodies fixed to blood basophils or tissue mast cell Subsequent exposure antigens combined with IgE antibody De-granulation of mass cells releasing chemical mediators Vasodilatation mucosal oedema, eosonophils Excessive secretion Smooth muscle contraction
Priming Effect
Acute or early phase Late or delayed phase
CLINICAL FEATURES
No age bar 12-16 years of age
Cardinal Symptoms
Seasonal:
Sneezing
Perennial
Not so severe Frequent colds Stuffy nose Lose of smell Post nasal drip Chronic cough Hearing impairment
Nasal obstruction
Watery nasal discharge Itching nose
Diagnosis
Detail history and physical examination
INVESTIGATIONS
Total and differential count Nasal smear Skin test Radioallergosorbent test (RAST) Nasal provocation test
COMPLICATIONS
Sinusitis Nasal polyp Serous otitis media Orthodontic problem Bronchial asthma
TREATMENT
Avoidance of allergens Treatment with drugs Immuno therapy
o TREATMENT WITH DRUGS Anti histaminics Cetrizine, levocetrizine, loratidine, des loratidine, terfenadine, fexofenadine, Rupatadine, cyproheptadine, azatadine maleate, ebastine,clemastine,mizolastine,azelastine Astemizole,diphenhydramine,hydroxyzine,chlorpheniramine,pheniramine maleate Ketotifen, sodium cromoglycate, dimethindene maleate, bresol, misc.allergic preparation
Topical use Phenylephrine, oxymetazoline, xylometazoline, naphazoline Rebound congestion leading to rhinitis medicamentosa
CORTICOSTEROIDS
ORAL USE Use in acute episode
TOPICAL STEROIDS Beclomethasone dipropionate,budesomide,flunisolide,acetate,fluticasone,mometasone Treatment for rhinitis medicamentosa 3 weeks not recommended Growth of fungus Break for 1-2 weeks every 2-3 months
SODIUM CHROMOGLYCATE Stabilises mast cells and prevent degranulation 2% solution as drops or spray or an aerosol powder Use both in seasonal and perennial
IMMUNOTHERAPY
When drug fail Allergen given in gradual increasing dose Suppresses formation of IgE Raises titre of specific IgG antibody Given for 1 year Discontinued if uninterrupted treatment for 3 year fails